Corticosteroids in acute respiratory failure

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 4, 1999, Pages 1079-1100

  Jantz, Michael A ^a   Sahn, Steven A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; AMINOSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; BLEOMYCIN; BRONCHODILATING AGENT; COCAINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HYDROCORTISONE; ISONIAZID; METHYLPREDNISOLONE; MITOMYCIN; NEUROMUSCULAR BLOCKING AGENT; PLACEBO; PREDNISOLONE; PREDNISONE; STREPTOMYCIN; VECURONIUM;

ACUTE RESPIRATORY FAILURE; ANAPHYLAXIS; ASTHMATIC STATE; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG ACTIVITY; DRUG MECHANISM; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; INTERSTITIAL PNEUMONIA; LUNG HEMORRHAGE; MALE; MILIARY TUBERCULOSIS; MYOPATHY; NEUROLOGIC DISEASE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REVIEW;

EID: 0032826555     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.4.9901075     Document Type: Review

References (326)

1. Stellato, C., L. M. Schwiebert, and R. P. Schleimer. 1997. Mechanisms of glucocorticosteroid action. In P. J. Barnes, M. M. Grunstein, A. R. Leff, and A. J. Woolcock, editors. Asthma. Lippineott-Raven, Philadelphia. 1569-1596.
2. Barnes, P. J., and J. M. Adcock. 1997. Glucocorticoid receptors. In R. G. Crystal, J. B. West, P. J. Barnes, and E. R. Weihel, editors. The Lung: Scientific Foundations, 2nd ed. Lippincott-Raven, Philadelphia. 37-55.
3. Pratt, W. B. 1993. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem. 268:21455-21458.
4. Tai, P. K. K., M. W. Albers, H. Chang, L. E. Faber, and S. L. Schrieber. 1992. Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. Science 256:1315-1318.
5. Yammamoto, K. R. 1985. Steroid receptor regulated transcription of specific genes and gene networks. Anna. Rev. Genet. 19:209-252.
6. Tsai, M. J., and B. W. O'Malley.1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev Biochem, 63:451-486.
7. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad.. Sci. U.S.A. 91:752-756.
8. Akerblom, I. E., E. P. Slater, M. Bcato, J. D. Baxter, and P. L. Mellon. 1998. Negative ragulation by glucocorticoids through interference with cAMP responsive enhancer. Science 241:350-353.
9. Jonat, C., H. J. Rahmsdorf, K. K. Park, A. C. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Anti-tumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204.
10. Yang-Yen, H.F., J. C. Chumbard, Y. L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.
11. Lane, S. J., and T. H. Lee. 1996. Corticosteroids: chemistry and mode of action. In A. R. Leff, editor, Pulmonary and Critical Care Pharmacology and Therapeutics. McGraw-Hill, New York. 553-560.
12. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
13. Kern, J. A., R. J. Lamb, J. C. Reed, R. P. Daniele, and P. C. Nowell. 1988. Dexamethasone inhibition of interleukin-1β production by human monocytes. Clin. Invest. 81:237-244.
14. Barnes, P. J. 1996. Mechanisms of action of glucocorticoids in asthma. Am. J. Respir. Crit. Care Med. 154:S21-S27.
15. Karin, M., and F. Saatcioglue. 1996. Negative transcriptional regulation by the glucocorticoid receptor is responsible for the antiinflammatory activity of glucocorticoids. In R. Schleimer, W. Busse, and P. M. O'Byrne, editors. Inhaled Glucocorticoids in Asthma-Mechanisms and Clinical Action. Marcel Dekker, New York, 23-52.
16. Thompson, A. G., and T. C. Starzl. 1993. New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol. Rev. 136:71-98.
17. Northrup, J. P., K. S. Ullman, and G. R. Crabtree. 1993. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT). J. Biol. Chem. 268:2917-2923.
18. Paliogianni, F., A. Raptis S. S. Ahuja, S. M. Najjar, and D. T. Boumpas, 1993. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-I and NF-AT. J. Clin. Invest. 91:1481-1489.
19. Robbins, R. A., D. R. Springall, J. B. Warren, O. J. Kwon, L. D. Buttery, A. J. Wilson, I. M. Adcock, V. Riveros-Moreno, S. Moncada, and J. Polak. 1994. Inducible nitric oxide synthase is increased in murine lung epithelial cell by cytokine stimulation. Biochem. Biophys. Res. Commun. 198:835-843.
20. Robbins, R. A., P. J. Barnes, D. R. Springall, J. B. Warren, O. J. Kwon, L. D. Buttery, A. J. Wilson, D. A. Geller, and J. M. Polak. 1994. Expression of inducible nitric oxide synthase in human bronchial epithelial cells. Biochem. Biophys. Res. Commun. 203:209-218.
21. Di Rosa, M., M. Radomski, R. Carnuccio, and S. Moncada. 1990. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172:1246-1252.
22. Radomski, M. W., R. M. J. Palmer, and S. Moncada, 1990. Glucocorticoids inhibit the expression of an inducible, but not the constitute nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 87:10043-10049.
23. Xio, Q. W., Y. Kashiwarbara, and C. Nathan, 1994. Role of transcription factor NF-αB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705-4708.
24. O'Banion, M. K., V. D. Winn, and D. A. Young. 1992. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclo-oxygenase. Proc. Natl. Acad. Sci. U.S.A. 89:4888-4892.
25. Mitchell, J. A., M. G. Belvisi, P. Akarasereemom, R. A. Robbins, O. J. Kwon, J. Croxtall, P. J. Barnes, and J. R. Vane. 1994. Induction of cyclo-oxygenase-2 by cytokincs in human pulmonary epithelial cells: regulation by dexamethasone. Br. J. Pharmacol. 113:1008-1014.
26. Newton, R., I. M. Adcock, and P. J. Barnes. 1995. Stimulation of COX-2 message by cytokines or phorbol ester is preceded by a massive and rapid induction of NF-kB binding activity (abstract). Am. J. Respir. Crit. Care Med. 151:A165.
27. 2 production by blocking mRNA synthesis and post-trunscriptional expression. J. Biol. Chem. 265:12745-12748.
28. 2 is coupled to hormonolly regulated release of arachidonic acid. Proc. Natl. Acad. Sci. U.S.A. 89:6147-6151.
29. Andersson, S. E., C. Zackrisson, A. Hemsen, and J. M. Lundberg. 1992. Regulation of lung endothelin content by the glucocorticosteroid budesonide. Biochem. Biophys. Res. Commun. 188:1116-1121.
30. Vittori, E., M. Marini, and A. Fasoli. 1992. Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids. Am. Rev. Respir. Dis. 146:1320-1325.
31. Barnes, P. J. 1995. Beta-adrenergic receptors and their regulation: state of the art. Am. J. Respir. Crit. Care Med. 152:838-860.
32. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giri, S. K. Dower, J. F. Sims, and A. Mantovani. 1993. Interleukin-I type II receptor: a decoy target for IL-I that is regulated by IL-4. Science 261:472-475.
33. Re, F., M. Muzio, M. De Rossi, N. Polentarutti, J. G. Giri, A. Mantovani, and F. Colotta. 1994. The type II "receptor" as a decoy target for interleukin I in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J. Exp. Med. 179:739-743.
34. Cronstein, B. N., S. C. Kimmel, R. I. Levin, F. Martiniuk, and G. Weissmann. 1992. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule. Proc. Natl. Acad. Sci. U.S.A. 89:9991-9995.
35. van de Stolpe, A., E. Caldenhoven, J. A. M. Raaijmakers, P. T. van der Saag, and L. Koenderman. 1993. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytes and bronchial epithelial cell lines. Am. J. Respir. Cell Mol. Biol. 8:340-347.
36. van de Stolpe, A., E. Caldenhoven, B. G. Stade, L. Koenderman, J. A. Raaijmakers, J. P. Johnson, and P. T. van der Saag. 1994. 12-O-tetradecanoylphorhol-13-acetate and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone: functional analysis of the human intercellular adhesion molecule-1 promoter. J. Biol. Chem. 269:6185-6192.
37. Abbinate-Nissen, J. M., L. G. Simpson, and G. D. Leikauf. 1995. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 12:L601-L606.
38. Schleimer, R. P. 1990. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am. Rev. Respir. Dis. 141:859-869.
39. Lane, S. J., J. R. W. Wilkinson, G. M. Cochrane, T. H. Lee, and J. P. Arm. 1993, Differential in vitro regulation by glucocorticoids on monocyte-derived cytokine generation in glucocorticoid-resistant bronchial asthma. Am. Rev. Respir. Dis. 147:690-696.
40. Snyder, D. S. and E. R. Unanue. 1982. Corticosteroids inhibit murine macrophage Ia expression and interleukin-I production. J. Immunol. 129:1803-1805.
41. Waage, A., and O. Bakke, 1988. Glucocorticoids suppress the production of tumor necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 63:299-302.
42. Veechiarelli, A., A. Siracusa, E. Cenci, M. Puliti, and G. Abbriti. 1992. Effect of corticosteroid treatment on interleukin-l and tumor necrosis factor secretion by monocytes from subjects with asthma. Clin. Exp. Allergy 22:365-370.
43. Murch, S., T. T. MacDonald, C. S. Wood, and K. L. Costeloe. 1992, Tumor necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 47:44-47.
44. Van Otteren, G. M., T. J. Standiford, S. L. Kunkel, J. M. Danforth, M. D. Burdick, L. V. Albruzzo, and R. M. Stricter. 1994. Expression and regulation of macrophage inflammatory protein-1α by murine alveolar and peritoneal macrophages. Am. J. Respir. Cell Mol. Biol. 10:8-15.
45. Poon, M., J. Megyesi, R. S. Green, H. Zhang, B. J. Rollins, R. Safirstein, and M. B. Taubman. 1991. In vivo and in vitro inhibition of JE gene expression by glucocorticoids. J. Biol. Chem. 266:22375-22379.
46. Lamas, A. M., G. V. Marcotte, and R. P. Schleimer. 1989. Human endothelial cells prolong cosinophil survival: regulation by cytokines and glucocorticosteroids. J. Immunol. 142:3978-3984.
47. Wallen, N., H. Kita, D. Weiller, and G. J. Gleich. 1991. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J. Immunol. 147:3490-3495.
48. Kita, H., R. Abu-Ghazaleh, C. J. Sanderson, and G. J. Gleich. 1991. Effect of steroids on immunoglobulin-induced eosinophil degranulation. J. Allergy Clin. Immunol. 87:70-77.
49. Lamas, A. M., O. G. Leon, and R. P. Schleimer. 1991. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J. Immunol. 147:254-259.
50. Lee, S. W., A. P. Tsou, H. Chan, J. Thomas, K. Petrie, E. M. Eugui, and A. C. Allison. 1988. Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin-1β mRNA. Proc. Natl. Acad. Sci. U.S.A. 85:1204-1208.
51. Fernandez-Ruiz, E., A. Rebello, M. A. Nieto, E. Sanz, C. Somoza, F. Ramirez, A. Lopez-Rivas, and A. Silva. 1989. IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids: synergistic effect of IL-2 and dexamethasone in the induction of high-affinity IL-2 receptors. J. Immunol. 143:4146-4151.
52. Kunicke, J., M. Talle, G. Denhardt, M. Brown, and L. Prince. 1993. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell Immunol. 148:39-49.
53. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma. J. Allergy Clin. Immunol. 90:32-42.
54. Shimura, S., T. Sasaki, K. Ikeda, K. Yamauchi, H. Sasaki, and T. Takishima. 1990. Direct inhibitory action of glucocorticoid on glycoconjugate secretion from airway submucosal glands. Am. Rev. Respir. Dis. 141:1044-1049.
55. Lundgren, J. D., M. A. Kallner, and J. H. Shelhamer. 1990. Mechanisms by which glucocorticosteroids inhibit secretion of mucus in asthmatic airways. Am. Rev. Respir. Dis. 141:S52-S58.
56. Carnuccio, R., M. Di Rosa, B. Guerrasio, T. Iuvone, and L. Satcbin. 1987. Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. Br. J. Pharmacol. 90:443-445.
57. Boschetto, P., D. F. Rogers, L. M. Fabbri, and P. J. Barnes. 1991. Corticosteroid inhibition of airway microvascular leakage. Am. Rev. Respir. Dis. 143:605-609.
58. Erjefalt, I., and C. G. A. Persson. 1991. Pharmacologic control of plasma exudation into tracheobronchial airways. Am. Rev. Respir. Dis. 143:1008-1014.
59. Williams, T. J., and H. Yarwood. 1990. Effect of glucocorticosteroids on microvascular permeability. Am. Rev. Respir. Dis. 141:539-543.
60. Wiegers, G. J., and M. H. M. Reul. 1998. Induction of cytokine receptors by glucocorticoids: functional and pathologic significance. Trends Pharmacol Sci. 19:317-321.
61. Wilckens, T., and R. De Rijk. 1997. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol. Today 18:418-424.
62. Chin, R., Jr., D. C. Eagerton, and M. Salem. 1994. Corticosteroids. In B. Chernow, editor. The Pharmacologic Approach to the Critically Ill Patient, 3rd ed. Williams & Wilkins, Baltimore. 715-740.
63. Greos, L. S., P. Vichyanond, D. C. Bleodow, C. G. Irvin, G. L. Larsen, S. J. Szefler, and M. R. Hill. 1991. Methylprednisolone achieves greater concentration in the lung than prednisolone: a pharmacokinetic analysis. Am. Rev. Respir. Dis. 144:586-592.
64. Weigelt, J. A., J. F. Norcross, K. R. Borman, and W. H. Snyder III. 1985. Early steroid therapy for respiratory failure. Arch. Surg. 120:536-540.
65. Luce, J. M., B. Montgomery, J. D. Marks, J. Turner, C. A. Metz, and J. F. Murray. 1988. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am. Rev. Respir. Dis. 138:62-68.
66. Bone, R. C., C. J. Fisher, Jr., T. P. Clemmer, G. J. Slotman, and C. A. Metz. 1987. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 92:1032-1036.
67. Bernard, G. R., J. M. Luce, C. L. Sprung, J. E. Rinaldo, R. M. Tate, W. J. Sibbald, K. Kariman, S. Higgins, R. Bradley, C. A. Metz, T. R. Harris, and K. L. Brigham. 1987. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N. Engl. J. Med. 317:1565-1570.
68. Ashbaugh, D. G., and R. V. Maier. 1985. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Arch. Surg. 120:530-535.
69. Hooper, R. G., and R. A. Kearl. 1990. Established ARDS treated with a sustained course of adrenocortical steroids. Chest 97:138-143.
70. Hooper, R. G., and R. A. Kearl. 1996. Established adult respiratory distress syndrome successfully treated with coticosteroids. South. Med. J. 89:359-451.
71. Biffl, W. L., F. A. Moore, E. E. Moore, J. B. Haenel, R. C. McIntyre, and J. M. Burch. 1995. Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome? Am. J. Surg. 170:591-596.
72. Meduri, G. U., J. M. Belenchia, R. J. Estes, R. G. Wunderink, M. El Torky, and K. V. Leeper. 1991. Fibroproliferative phase of ARDS: clinical findings and effects of corticosteroids. Chest 100:943-952.
73. Meduri, G. U., A. J. Chinn, K. V. Leeper, R. G. Wunderink, E. Tolley, H. T. Winer-Muram, V. Khare, and M. El Torky. 1994. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome. Chest 105:1516-1527.
74. Meduri, G. U., S. Headley, E. Golden, S. J. Carson, R. A. Umberger, T. Kelso, and E. A. Tolley. 1998. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. J.A.M.A. 280:159-165.
75. Meduri, G. U. 1996. The role of the host defense response in the progression and outcome of ARDS: pathophysiologic correlations and response to glucocorticoid treatment. Eur. Respir. J. 9:2650-2670.
76. Meduri, G. U., S. Headly, G. Kohler, F. Stentz, E. Tolley, R. Umberger, and K. Leeper. 1995. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1β and IL-6 are consistent and efficient predictors of outcome over time. Chest 107:1062-1073.
77. Meduri, G. U., G. Kohler, S. Headley, E. Tolley, F. Stentz, and A. Postlethwaite. 1995. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest 108:1303-1314.
78. Tutor, J. D., C. M. Mason, E. Dobard, K. C. Beckerman, W. R. Summer, and S. Nelson. 1994. Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am. J. Respir. Crit. Care Med. 149:1107-1111.
79. Roumen, R. M., T. Hendricks, J. van der Jongekrijg, G. A. Nieuwenhuijzen, R. W. Sauerwein, J. W. van der Meer, and R. J. Goris. 1993. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann. Surg. 218:769-776.
80. Almawi, W. Y., M. L. Lipman, A. C. Stevens, B, Zanker, E. T. Hadro, and T. B. Strom. 1991. Abrogation of glucocorticosteroid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-γ. J. Immunol. 146:3523-3527.
81. Kam, J. C., S. J. Szefler, W. Surs, E. R. Sher, and D. Y. M. Leung, 1993. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. 153:3460-3466.
82. Meduri, G. U., S. Headley, E. Tolley, M. Shelby, F. Stentz, and A. Postlethwaite. 1995. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest 108:1315-1325.
83. Meduri, G. U., E. A. Tolley, A. Chinn, F. Stentz, and A. Postlewaite. 1998. Procollagen types I and III aminoterminal propeplide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am. J. Respir. Crit. Care Med. 158:1432-1441.
84. Entzian, P., A. Huckstadt, H. Kreipe, and J. Barth. 1990. Determination of serum concentrations of type III procollagen peptide in mechanically ventilated patients: pronounced augmented concentrations in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 142:1079-1082.
85. Waydhas, C., D. Nast-Kolb, A. Trupka, S. Lenk, K. H. Duswald, L. Schweiberer, and M. Jochum. 1993. Increased serum concentrations of procollagen type III peptide in severely injured patients: an indication of fibrosing activity? Crit. Care Med. 21:240-247.
86. Clark, J. G., J. A. Milberg, K. P. Steinberg, and L. D. Hudson. 1995. Type III procollagen peptide in the adult respiratory distress syndrome. Ann. Intern. Med. 122:17-23.
87. Hesterberg, T. W., and J. A. Last, 1981. Ozone-induced acute pulmonary fibrosis in rats-prevention of increased rates of collagen synthesis by methylprednisolone. Am. Rev. Respir. Dis. 123:47-52.
88. Hakkinen, P. J., R. L. Schmoyer, and H. P. Witschi. 1983, Potentiation of butylated-hydroxytoluene-induced acute lung damage by oxygen: effects of prednisolone and indomethacin. Am. Rev. Respir. Dis. 128:648-651.
89. Kehrer, J. P., A. J. P. Klein-Szanto, E. M. B. Sorensen, R. Pearlman, and M. H. Rosner. 1984. Enhanced acute lung damage following corticosteroid treatment. Am. Rev. Respir. Dis. 130:256-261.
90. Fanta, C. H., T. H. Rossing, and E. R. McFadden. 1983. Glucocorticoids in acute asthma: a critical controlled trial. Am. J. Med. 74:845-851.
91. Younger, R. E., P. S. Gerber, H. G. Herrod, R. M. Cohen, and L. V. Crawford. 1987. Intravenous methylprednisolone efficacy in status asthmaticus of childhood. Pediatrics 80:225-230.
92. Pierson, W. E., C. W. Bierman, and V. C. Kelley. 1974. A double-blind triai of corticosteroid therapy in status asthmaticus. Pediatrics 54:282-288.
93. Collins, J. V., T. J. H. Clark, D. Brown, and J. Townsend. 1975. The use of corticostcroids in the treatment of acute asthma. Q. J. Med. 174:259-273.
94. Kattan, M., D, Gurwitz, and H. Levison. 1980. Corticosteroids in status asthmaticus. J. Pediatr. 96:596-599.
95. Sue, M. A., F. K. Kwong, and W. B. Klaustermeyer, 1986. A comparison of intravenous hydrocortisone, methylprednisolone, and dexamethasone in acute bronchial asthma. Ann. Allergy 56:406-409.
96. Svedmyr, N. 1990. Action of corticosteroids on beta-adrenergic receptors. Am. Rev. Respir. Dis. 141:S31-S38.
97. McFadden, E. R., R. Kiser, W. J. deGroot, B. Holmes, R, Kiker, and G. Viser. 1976. A controlled study of the effects of single doses of hydrocortisone on the resolution of acute attacks of asthma. Am. J. Med. 60:52-59.
98. Ramsdell, J. W., C. C. Berry, and J. L Clausen. 1983. The immediate effects of cortisol on pulmonary function in normals and asthmatics. J. Allergy Clin. Immunol. 71:69-74.
99. Morell, F., R. Orriols, J. de Gracia, V. Curull, and A. Pujol. 1992. Controlled trial of intravenous corticosteroids in severe acute asthma. Thorax 47:588-591.
100. Luksza, A. R. 1982. Acute severe asthma treated without steroids. Br. J. Dis. Chest 76:15-19.
101. Barnes, P. J., A. P. Greening, and C. K. Crompton. 1995. Glucocorticoid resistance in asthma. Am. J. Respir. Crit. Care Med. 152:S125-S142.
102. Adcouk, I. M. 1996. Steroid resistance in asthma: molecular mechanisms. Am. J. Respir. Crit. Care Med. 154:S58-S61.
103. Haskell, R. J., B. M. Wong, and J. H. Hansen. 1983. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch. Intern. Med. 143:1324-1327.
104. Marquette, C. H., B. Stach, E. Cardot, J. F. Bervar, F. Saulnier, J. J. Lafitte, P. Goldstein, B. Wallaert, and A. B. Tonnel. 1995. High-dose and low-dose systemic corticosteroids are equally efficient in acute severe asthma. Eur. Respir. J. 8:22-27.
105. Bowler, S. D., C. A. Mitchell, and J. G. Armstrong. 1992. Corticosteroids in acute severe asthma: effectiveness of low doses. Thorax 47:584-587.
106. Raimondi, A. C., J. C. Figueroa-Casas, and A. J. Roncoroni. 1986. Comparison between high and moderate doses of hydrocortisone in the treatment of status asthmaticus. Chest 89:832-835.
107. Ratio, D., C. Alfaro, J. Sipsey, M. M. Glovsky, and O. P. Sharma. 1988. Are intravenous corticosteroids required in status asthmaticus? J.A.M.A. 260:527-529.
108. Albert, R. K., T. R. Martin, and S. W. Lewis. 1980. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann. Intern. Med. 92:753-758.
109. Glenny, R. W. 1987. Steroids in COPD: the scripture according to Albert. Chest 91:289-290.
110. Rubini, F., C. Rampulla, and S. Nava, 1994. Acute effect of corticosteroids on respiratory mechanics in mechanically ventilated patients with chronic airflow obstruction and acute respiratory failure. Am. J. Respir. Crit. Care Med. 149:306-310.
111. Emerman, C. L., A. F. Connors, T. W. Lukens, M. E. May, and D. Effron. 1989. A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD. Chest 95:563-567.
112. Levine, S. J. 1996. Pneumocystis crainii. Clin. Chest Med. 17:665-695.
113. Tietjen, P. A., and D. E. Stover, 1995. Pneumocystis carinli pneumonia. Semin. Respir. Crit. Care Med. 16:173-186.
114. Moe, A. A., and W. D. Hardy. 1994, Pneumocyitls carinli infection in the HIV-seropositive patient. Infect. Dis. Clin. North Am. 8:331-364.
115. Hoover, D. R., A. J. Saah, H. Bacellar, J. Phair, R. Detels, R. Anderson, and R. A. Kaslov. 1993. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis, N. Engl. J. Med. 329:1922-1926.
116. De Palo, V. A., B. H. Millstein, P. H. Mayo, S. H. Salzman, and M. J. Rosen, 1995. Outcome of intensive care in patients with HIV infection, Chest 107:506-510.
117. Murray, J. F., C. P. Felton, S. M. Garay, M. S. Gottlieb, P. C. Hopewell, D. E. Stover, and A. S. Teirstein. 1984. Pulmonary complications of the acquired immunodeficiency syndrome: report of a National Heart, Lung, and Blood Institute workshop. N. Engl. J. Med. 310:1682-1688.
118. Wachter, R. M., J. M. Luce, J. Turner, P. Volberding, and P. C. Hopewell. 1986. Intensive care of patients with the acquired immunodeficiency syndrome: outcome and changing pattern of utilization. Am. Rev. Respir. Dis. 134:891-896.
119. MacFadden, D. K., J. D. Edelson, and A. S. Rebuck. 1985. Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: response to inadvertent steroid therapy. Can. Med. Assoc. J. 132:1161-1163.
120. Foltzer, M. A., S. E. Hannan, and A. J. Kozak. 1985. Pneumocystis pneumonia: response to corticosteroids. J.A.M.A. 253:979.
121. Rankin, J. A., and J. A. Pella. 1987. Radiographic resolution of Pneumocystis carinii pneumonia in response to corticosteroid therapy. Am. Rev. Respir. Dis. 136:182-183.
122. MacFadden, D. K., R. H. Hyland, T. Inouye, J. D. Edelson, C. H. Rodriguez, and A. S. Rebuck. 1987. Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet 1:1477-1479.
123. Walmsley, S., I. E. Salit, and J. Brunton, 1988. The possible role of corticosteroid therapy for Pneumocystis pneumonia in the acquired immune deficiency syndrome (AIDS). J. Acquir. Immune Defic. Syndr. 1:354-360.
124. Montaner, J. S. G., J. A. Russell, L. Lawson, and J. Ruedy. 1989. Acute respiratory failure secondary to Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a potential role for systemic corticosteroids. Chest 95:881-884.
125. Schiff, M. J., B. F. Farber, and M. H. Kaplan. 1990. Steroids for Pneumocystis carinii pneumonia and respiratory failure in the acquired immunodeficiency syndrome: a reassessment. Arch. Intern. Med. 150:1819-1821.
126. Clement, M., R. Edison, J. Turner, B. Montgomery, J. Luce, D. Feigal, and P. Hopewell. 1989. Corticosteroids as adjunctive therapy in severe Pneumocystis corinii pneumonia: a prospective placebo-controlled trial (abstract). Am. Rev. Respir. Dis. 139:A250.
127. Montaner, J. S. G., L. M. Lawson, N. Levitt, A. Belzberg, M. T. Schechter, and J. Ruedy. 1990. Corticosteroids prevent early deterioration in patients with moderately severe Pneumorystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 113:14-20.
128. Gagnon, S., A. M, Boota, M. A. Fischl, H. Baier, O. W. Kirksey, and L. La Voie. 1990. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N. Engl. J. Med. 323:1444-1450.
129. Bozzette, S. A., F. R., Sattler, J. Chiu, A. W. Wu, D., Gluckstein, C. Kemper, A. Bartok, J. Niosi, I. Abramson, J. Coffman, C. Hughlett, R. Loya, B, Cassens, B. Akil, T. Z. Meng, C. T. Boylen, D. Nielsen, D. D. Richman, J. G. Tilles, J. Leedum, J. A. McCutchan, and the California Collaborative Treatment Group. 1990. A controlled trial of early adjunetive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N. Engl. J. Med. 323:1451-1457.
130. Sleasman, J. W., C. Hemenway, A. S. Klein, and D. J. Barrett, 1991 Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia. A.J.D.C. 147:30-34.
131. McLaughlin, G. E., S. S. Virdee, C. L. Schleien, H. H. Holzman, and G. B. Scott. 1995. Effect of cortieosteroids on survival of children with acquired immunodeficiency syndrome and Pneumocystis carinii-related respiratory failure. J. Pediatr. 126:821-824.
132. Bye, M. R., A. M. Cairns-Bazarian, and J. M. Ewig. 1994. Markedly reduced mortality associated with corticosteroid therapy of Pneumocystis carinii pneumonia in children with acquired immunodeficiency syndrome. Arch. Pediatr. Adolesc. Med. 148:638-641.
133. Peters, S. G., and U. B. S. Prakash. 1987. Pneumocystis carinii pneumonia: review of 53 cases. Am. J. Med. 82:73-78.
134. Sepkowiz, K. A., A. E. Brown, E. E. Telzak, S. Gottlieb, and D. Armstrong. 1992. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. J.A.M.A. 267:832-837.
135. Arend, S. M., F. P. Kroon, and J. W. van't Wout. 1995. Pneumocystis carinii pneumonia in patients without AIDS. 1980 through 1993: an analysis of 78 cases. Arch. Intern. Med. 155:2436-2441.
136. Ewig, S., T. Bauer, C. Schneider, A. Pickenhain, L. Pizzulli, U. Loos, and B. Luderitz. 1995. Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur. Respir. J. 8:1548-1553.
137. Tuan, I. Z., D. Dennison, and D. J. Weisdorf. 1992. Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transpl. 10:267-272.
138. Godeau, B., V. Coutant-Peronne, D. L. T. Huong, L. Guillevin, G. Magadur, M. de Bandt, S. Dellion, J. Rossert, G. Rostoker, J. C. Piette, and A. Schaeffer. 1994. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J. Rheumatol. 21:246-251.
139. Pareja, J. G., R. Garland, and H. Koziel. 1998. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 113:1215-1224.
140. Lambertus, M. W., M. B. Goetz, A. R. Murthy, and G. E. Mathison. 1990. Complications of corticosteroid therapy in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Chest 98:38-43.
141. Gallant, J. E., R. E. Chaisson, and R. D. Moore. 1998. The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications. Chest 114:1258-1263.
142. Jones, B. E., E. K. Taikwel, A. L. Mercado, S. U. Sian, and P. F. Barnes. 1994. Tuberculosis in patients with HIV infection who receive corticosteroids for presumed Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med. 149:1686-1688.
143. Martos, A., D. Podzamczer, J. Martinez-Lacasa, G. Rufi, M. Santin, and F. Gudiol. 1995. Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia. AIDS 9:1037-1041.
144. Jensen, A. M., J. D. Lundgren, T. Benfield, T. L. Nielsen, and J. Vestbo. 1995. Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution. Chest 108:411-414.
145. National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. 1990. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N. Engl. J. Med. 323:1500-1504.
146. Allen, J. N., E. R. Pacht, J. E. Gadek, and W. B. Davis. 1989. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N. Engl. J. Med. 321:569-574.
147. Badesch, D. B., T. E. King, and M. I. Schwarz. 1989. Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am. Rev. Respir. Dis. 139:249-252.
148. St. John, R. C., J. N. Allen, and E. R. Pacht. 1990. Postoperative respiratory failure due to acute eosinophilic pneumonia. Intensive Care Med. 16:408-410.
149. Buchheit, J., N. Eid, G. Rodgers Jr., T. Feger and O. Yakoub. 1992. Acute eosinophilic pneumonia with respiratory failure: a new syndrome? Am. Rev. Respir. Dis. 145:716-718.
150. Umeki, S. 1992. Reevaluation of eosinophilic pneumonia and its diagnostic criteria. Arch. Intern. Med. 152:1913-1919.
151. Ogawa, H., M. Fujimura, T. Matsuda, H. Nakamura, I. Kumabashiri, and S. Kitagawa. 1993. Transient wheeze: eosinophilic bronchiolitis in acute eosinophilic pneumonia. Chest 104:493-496.
152. Hayakawa, H., A. Sato, M. Toyoshima, S. Imokawa, and M. Taniguchi. 1994. A clinical study of idiopathic eosinophilic pneumonia. Chest 105:1462-1466.
153. Iwami, T., S. Umemoto, K. Ikeda, H. Yamada, and M. Matsuzaki. 1996. A case of acute eosinophilic pneumonia: evidence for hypersensitivity-like pulmonary reaction. Chest 110:1618-1621.
154. Cheon, J. E., K. S. Lee, G, S. Jung, M. H. Chung, and Y. D. Cho. 1996. Acute eosinophilic pneumonia: radiographic and CT findings in six patients. A.J.R. 167:1195-1199.
155. Pope-Harman, A. L., W. B. Davis, E. D. Allen, A. J. Christoforidis, and J. N. Allen. 1996. Acute eosinophilic pneumonia: a summary of 15 cases and review of the literature. Medicine 75:334-342.
156. Tazelaar, H. D., L. J. Linz, T. V. Colby, J. L. Myers, and A. H. Limper. 1997. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am. J. Respir. Crit. Care Med. 155:296-302.
157. Alp, H., R. S. Daum, C. Abrahams, and M. E. Wylam. 1998. Acute eosinophilic pneumonia: a cause of reversible, severe, noninfectious respiratory failure. J. Pediatr. 132:540-543.
158. Allen, J. N., W. B. Davis, and E. R. Pacht. 1990. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am. Rev. Respir. Dis. 142:642-647.
159. Allen, J. N., and W. B. Davis. 1994. Eosinophilic lung diseases: state of the art. Am. J. Respir. Crit. Care Mad. 150:1423-1438.
160. Ricker, D. H., S. R. Taylor, J. C. Gartner, and G. Kurland. 1991. Fatal pulmonary aspergillosis presenting as acute eosinophilic pneumonia in a previously healthy child. Chest 100:875-877.
161. Meeker, D. P., G. N. Gephardt, E. M. Cordasco, and H. P. Wiedemann. 1991. Hypersensitivity pneumonitis versus pulmonary aspergillosis: two cases with unusual pathologic findings and review of the literature. Am. Rev. Respir. Dis. 143:431-436.
162. Libby, D. M., T. F. Murphy, A. Edwards, G. Gray, and T. K. C. King. 1980. Chronic eosinophilic pneumonia: an unusual cause of acute respiratory failure. Am. Rev. Respir. Dis. 122:497-500.
163. Ivanick, M. J., and J. F. Donohue. 1986. Chronic eosinophilic pneumonia: a cause of adult respiratory distress syndrome. South. Med. J. 79:686-690.
164. Marino, C. T., and L. P. Pertschuk. 1981. Pulmonary hemorrhage in systemic lupus erythematosus. Arch. Intern. Med. 141:201-203.
165. Myers, J. L., and A. A. Katzenstein. 1986. Microangiitis in lupus-induced pulmonary hemorrhage. Am. J. Clin. Pathol. 85:552-556.
166. Abud-Mendoza, C., E. Diaz-Jouanen, and D. Alarcon-Segovia. 1985. Fatal pulmonary hemorrhage in systemic lupus erythematosus: occurrence without hemoptysis. J Rheumatol. 12:558-561.
167. Mintz, G., L. F. Galindo, J Fernandez-Diez, F. J. Jimenez, E. Robles-Saavedra, and R. D. Enriquez-Casillas. 1978. Acute massive pulmonary hemorrhage in systemic lupus erythematosus. J. Rheumatol 5:39-50.
168. Eagen, J. W., V. A. Memoli, J. L. Roberts, G. R. Matthew, M. M. Schwartz, and F. J. Lewis. 1978. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine 57:545-560.
169. Zamora, M. R., M. Laird Warner, R. Tuder, and M. I. Schwarz. 1997. Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome. Medicine 76:192-202.
170. Schwab, E. P., H. R. Schumacher, Jr., B. Freundlich, and P. E. Callegari. 1993. Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin. Arthritis Rheum. 23:8-15.
171. Orens, J. B., F. J. Martinez, and J. P. Lynch III 1994. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 20:159-193.
172. Boumpas, D. T., H. A, Austin III, B. J. Fessler, J. E. Balow, J. H. Klippel, and M. D. Lockshin. 1995. Systemic lupus erythematosus: emerging concepts: part I. Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann. Intern. Med. 122:940-950.
173. Fauci, A. S., B. F. Haynes, P. Kate, and S. M. Wolff. 1983. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann. Intern. Med. 98:76-85.
174. Colby, T. V. 1989. Diffuse pulmonary hemorrhage in Wegener's granulomatosis. Semin. Respir. Med. 10:136-140.
175. Leatherman, J. W., S. F. Davies, and J. R. Hoidal. 1984. Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine 63:343-361.
176. Travis, W. D., H. A. Carpenter, and J. T. Lie. 1987. Diffuse pulmonary hemorrhage: an uncommon manifestation of Wegener's granulomatosis. Am. J. Surg. Pathol. 11:702-708.
177. Green, R. J., S. J. Ruoss, S. A. Kraft, G. J. Berry, and T. A. Raffin. 1996. Pulmonary capillaritis and alveolar hemorrhage: update on diagnosis and management. Chest 110:1305-1316.
178. Myers, J. L., and A. A. Katzenstein. 1987. Wegener's granulomatosis presenting with massive pulmonary hemorrhage und capillaritis. Am. J. Surg. Pathol. 11:895-898.
179. Misset, B., D. Glotz, D. Nochy, J. Bosq, E. Gilles, B. Leclercq, and G. Nitenberg. 1991. Wegener's granulomatosis presenting as diffuse pulmonary hemorrhage. Intensive Care Med. 17:118-120.
180. Stokes, T. C., B. G. McCann, R. T. Rees, E. H. Sims, and B. D. W. Harrison. 1982, Acute fulminating intrapulmonary haemorrhage in Wegener's granulomatosis. Thorax 37:315-316.
181. Sachez-Masiques, J., and D. B. Ettensohn. 1989, Case report: alveolar hemorrhage in Wegener's granulomatosis. Am. J. Med. Sci. 297:390-393.
182. Haworth, S. J., C. O. S. Savage, D. Carr, J. M. B. Hughes, and A. J. Rees. 1985. Pulmonary haemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis. Br. Med. J. 290:1775-1778.
183. Hoffman, G. S., G. S. Kerr, R. Y. Leavitt, C. W. Hallahan, R. S. Lebovics, W. D. Travis, M. Rottem, and A. S. Fauci. 1992. Wegener's granulomatosis: an analysis of 158 patients. Ann. Intern. Med. 116:488-498.
184. Leatherman, J. W. 1987. Immune alveolar hemorrhage. Chest 91:891-897.
185. Sullivan, E. J., and G. S. Hoffman. 1998. Wegener's granulomatosis. Semin. Respir. Crit. Care Med. 19:13-25.
186. Jennette, J. C., and R. J. Falk. 1997. Small-vessel vasculitis. N. Engl. J. Med. 337:1512-1523.
187. Travis, W. D., T. V. Colby, C. Lombard, and H. A. Carpenter. 1990. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am. J. Surg. Pathol. 14:1112-1125.
188. Bosch, X., J. Font, E. Mirapeix, L. Revert, M. Ingelmo, and A. Urbano-Marquez. 1992. Antimyeloperoxidase autoantibody-associated necrotizing alveolar capillaritis. Am. Rev. Respir. Dis. 146:1326-1329.
189. Bosch, X., A. Lopez-Soto, E. Mirapeix, J. Font, M. Ingelmo, and A. Urbano-Marquez. 1994. Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Arch. Pathol. Lab. Med. 118:517-522.
190. Gaudin, P. B., F. B. Askin, R. J. Falk, and J. C. Jennette. 1995. The pathologic spectrum of pulmonary lesion? in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am. J. Clin. Pathol. 104:7-16.
191. Savage, C. O. S., C. G. Winearls, D. J. Evans, A. J. Rees, and C. M. Lockwood. 1985. Microscopic polyarteritis: presentation, pathology, and prognosis. Q. J. Med. 220:467-483.
192. Lhote, F., and L. Guillevin. 1998. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Semin. Respir. Crit. Care Med. 19:27-45.
193. Rees, A. J. 1984. Pulmonary injury caused by anti-basement membrane antibodies. Semin. Respir. Med. 5:264-271.
194. Young, K. R. 1989. Pulmonary-renal syndromes. Clin. Chest Med. 10:655-675.
195. Johnson, J. P., I. Moore, H. A, Austin III, J. E. Balow, T. T. Antonovych, and C. B. Wilson. 1985. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic, and treatment factors. Medicine 64:219-227.
196. Briggs, W. A., J. P. Johnson, S. Teichman, H. C. Yeager, and C. B. Wilson. 1979. Antiglomerular basement membrane antibody-mediated glomerulonephritis and Goodpasture's syndrome. Medicine 58:348-361.
197. Merkel, F., K. O. Netzer, O. Gross, M. Marx, and M. Weber. 1998. Therapeutic options for critically ill patients suffering from progressive lupus nephritis or Goodpasture's syndrome. Kidney Intl. 53(Suppl. 64):S31-S38.
198. Peters, D. K., A. J. Rees, C. M. Lockwood, and C. D. Pusey. 1982. Treatment and prognosis of anti-basement membrane antibody mediated nephritis. Transplant Proc. 14:513-521.
199. Robbins, R. A., J. Linder, M. G. Stahl, A. B. Thompson III, W. Haire, A. Kessinger, J. O. Armitage, M. Arneson, G. Woods, W. P. Vaughn, and S. I. Rennard. 1989, Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am. J. Med. 87:511-518.
200. Jules-Elysee, K., D. E. Stover, J. Yahalom, D. A. White, and S. C. Gulati. 1992. Pulmonary complications in lymphoma patients treated with high-dose therapy and autologous bone marrow transplantation. Am. Rev. Respir. Dis. 146:485-491.
201. Crilley, P., D. Topolsky, M. J. Styler, E. Bernstein, K. Resnick, R. Mullaney, S. Bulova, I. Brodsky, and D. I. Marks. 1995. Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophos-phamide and etoposide in 84 patients undergoing autologous and allogeneic bone marrow transplantation. Bone Marrow Transpl. 15:361-365.
202. Crawford, S. W., R. C. Hackman, und J. G. Clark. 1988. Open lung biopsy diagnosis of diffuse pulmonary infiltrates after marrow transplantation. Chest 94:949-953.
203. Agusti, C., J. Ramirez, C. Picado, A. Xaubet, E. Carreras, E. Ballester, A. Torres, C. Battochia, and R. Rodriguez-Roisin. 1995. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. Am. J. Respir. Crit. Care Med. 151:1006-1010.
204. Bojko, T., D. A. Notterman, B. M. Greenwald, W. J. De Bruin, M. S. Magid, and T. Godwin. 1995. Acute hypoxemic respiratory failure in children following bone marrow transplantation: an outcome and pathologic study. Crit. Care Med. 23:755-759.
205. Chao, N. J., S. R. Duncan, G. D. Long, S. J. Horning, and K. G. Blume. 1991. Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Ann. Intern. Med. 114:145-146.
206. Metcalf, J. P., S. I. Rennard, E. C. Reed, W. D. Haire, J. H. Sisson, T. Walter, and R. A. Robbins. 1994. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. Am. J. Med. 96:327-334.
207. Matthay, R. A., M. I. Schwarz, T. L. Petty, R. E. Stanford, R. G. Gupta, S. A. Sahn, and J. C. Steigerwald. 1974, Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine 54:397-409.
208. Wiedemann, H. P., and R. A. Matthay. 1989. Pulmonary manifestations of the collagen vascular diseases. Clin. Chest Med. 10:677-722.
209. Andonopoulos, A. P. 1991, Adult respiratory distress syndrome: an unrecognised premortem event in systemic lupus erythematosus. Br. J Rheum. 30:346-348.
210. Ibister, J. P., M. Ralston, J. M. Hayes, and R. Wright. 1981. Fulminant lupus pneumonitis with acute renal failure und RBC aplasia: successful management with plasmapheresis and immunosuppression. Arch. Intern. Med. 141:1081-1083.
211. Freter, S., M. Davidman, D. D. Bercovitch, and M. Brisson. 1994. Acute pulmonary edema as the initial hospital presentation of systemic lupus erythematosus. Arch. Intern. Med. 154:453-456.
212. Domingo-Pedrol, P., A. Rodriguez de la Serna, J. Mancebo-Cortes, and J. M. Sanchez-Segura. 1985. Adult respiratory distress syndrome caused by acute systemic lupus erythematosus. Eur. Respir. J. 67:141-144.
213. Inoue, T., Y. Kanayama, A. Ohe, N. Kato, T. Horiguchi, M. Ishii, and K. Shiota. 1979, Immunopathologic studies of pneumonitis in systemic lupus erythematosus. Ann. Intern. Med. 91:30-34.
214. Davison, A. G., B. E. Heard, W. A. C. McAllister, and M. E. H. Turner-Warwick. 1983. Cryptogenic organizing pneumonitis. Q. J. Med. 207:382-394.
215. Epler. G. R., T. V. Colby, T. C. McLoud, C. B. Carrington, and E. A. Gaensler. 1985. Bronchiolitis obliterans organizing pneumonia. N. Engl. J. Med. 312:152-158.
216. Cordier, J. F. 1993. Cryptogenic organizing pneumonitis: bronchiolitis obliterans organizing pneumonia. Clin. Chest Med. 14:677-692.
217. Boots, R. J., J. D. S. McEvoy, P. Mowat, and I. Le Fevre. 1995. Bronchiolitis obliterans organising pneumonia: a clinical and radiologic review. Aust. N.Z. J. Med. 25:140-145.
218. Guerry-Force, M. L., N. L. Muller, J. L. Wright, B. Wiggs, C. Coppin, P. D. Pare, and J. C. Hogg. 1987. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonitis, and small airways disease. Am. Rev. Respir. Dis. 135:705-712.
219. Izumi, T., M. Kitaichi, K. Nishimura, and S. Nagai. 1992. Bronchiolitis obliterans organizing pneumonia: clinical features and differential diagnosis. Chest 102:715-719.
220. Lohr, R. H., B. J. Boland, W. W. Douglas, D. H. Dockrell, T. V. Colby, S. J. Swensen, P. C. Wollan, and M. D. Silverstein. 1997. Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants. Arch. Intern. Med. 157:1323-1329.
221. Cordier, J. F., R. Loire, and J. Brune. 1989. Idiopathic bronchiolitis obliterans organizing pneumonia: definition of characteristic clinical profiles in a series of 16 patients. Chest 96:999-1004.
222. King, T. E., and R. L. Mortenson. 1992. Cryptogenic organizing pneumonitis: the North American experience. Chest 102:85-135.
223. Yamamoto, M., Y. Ina, M. Kitaichi, M. Harasawa, and M. Tamura. 1992. Clinical features of BOOP in Japan. Chest 102:21S-25S.
224. Cohen, A. J., T. E. King, and G. P. Downey. 1994. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am. J. Respir. Crit. Care Med. 149:1670-1675.
225. Nizami, I. Y., D. G. Kissner, D. W. Visscher, and B. A. Dubaybo. 1995. Idiopathic bronchiolitis obliterans with organizing pneumonia: an acute and life-threatening syndrome. Chest 108:271-277.
226. Iannuzzi M. C., D. C. Farhi, P. D. Bostrom, T. L. Petty, and J. H. Fisher. 1985. Fulminant respiratory and death in a patient with idiopathic bronchiolitis obliterans. Arch. Intern. Med. 145:733-734.
227. Schwarz, M. I. 1993. Diffuse pulmonary infiltrates and respiratory failure following 2 weeks of dyspnea in a 45-year-old woman. Chest 104:927-929.
228. Bellomo, R., M. Finlay, P. McLaughlin, and E. Tai. 1991. Clinical spectrum of cryptogenic organising pneumonitis. Thorax 46:554-558.
229. Costabel, U., H. Teschler, B. Schoenfeld, W. Hartung, A. Nusch, J. Guzman, D. Greschuchna, and N. Konietzko. 1992. BOOP in Europe. Chest 102:14S-20S.
230. Movsas, B., T. A. Raffin, A. H. Epstein, and C. J. Link, Jr. 1997. Pulmonary radiation injury. Chest 111:1061-1076.
231. Roach, M., 3rd, D. R. Gandara, H. S. You, P. S. Swift, S. Kroll, D. C. Shrieve, W. M. Wara, L. Margolis, and T. L. Philips. 1995. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J. Clin. Oncol. 13:2606-2612.
232. Gross, N. J. 1977. Pulmonary effects of radiation therapy. Ann. Intern. Med. 86:81-92.
233. Goldman, A. L., and R. Enquist. 1975. Hyperacute radiation pneumonitis. Chest 67:613-615.
234. Byhardt, R. W., R. Abrams, and U. Almargo. 1988. The association of adult respiratory distress syndrome (ARDS) with thoracic irradiation (RT). Int. J. Rad. Oncol. Biol. Phys. 15:1441-1446.
235. Gibson, P. G., D. H. Bryant, G. W. Morgan, M. Yeates, V. Fernandez, R. Penny, and S. N. Breit. 1988. Radiation-induced lung injury: a hypersensitivity pneumonitis? Ann. Intern. Med. 109:288-291.
236. Roswit, B., and D. C. White. 1977. Severe radiation injuries of the lung. Am. J. Roentgenol. 129:127-136.
237. Stone, D. J., M. J. Schwartz, and R. A. Green. 1956. Fatal pulmonary insufficiency due to radiation effect upon the lung. Am. J. Med. 21:211-226.
238. Gracey, D. R. 1975 Radiation pneumonitis producing respiratory failure. Heart Lung 4:452-455.
239. Fulkerson, W. J., R. E. McLendon, and L. R. Prosnitz. 1986. Adult respiratory distress syndrome after limited thoracic radiotherapy. Cancer 57:1941-1946.
240. Philips, T. L., M. D. Wharam, and L. W. Margolis. 1975. Modification of radiation injury to normal tissues by chemotherapeutic agents. Cancer 35:1678-1684.
241. Gross, N. J. 1980. Radiation pneumonitis in mice: some effects of corticosteroids on mortality and pulmonary physiology. J. Clin. Invest. 66:504-510.
242. Gross, N. J. K. R. Narine, and R. Wade. 1988. Protective effect of corticosteroids on radiation pneumonitis in mice. Radiat. Res. 113:112-119.
243. Loyd, J. E., J. M. Bolds, N. Wickersham, A. W. Malcolm, and K. L. Brigham. 1988. Corticosteroids prevent acute lung dysfunction caused by thoracic irradiation in unanesthetized sheep. Am. Rev. Respir. Dis 138:1227-1233.
244. Pezner, R. D., M. Bertrand, G. R. Cecchi, R. R. Paladugu, and B. R. Kendregan. 1984. Steroid-withdrawal radiation pneumonitis in cancer patients. Chest 85:816-817.
245. Castellino, R. A., E, Glatstein, M. M. Turbow, S. Rosenberg, and H. S. Kaplan. 1974. Latent radiation injury of lungs or heart activated by steroid withdrawal. Ann. Intern. Med. 80:593-599.
246. Parris, T. M., J. G. Knight, C. E. Hess, and W. C. Constable. 1979. Severe radiation pneumonitis precipitated by withdrawal of corticosteroids: a diagnostic und therapeutic dilemma. A.J.R. 132:284-286.
247. Rubin, O., and G. W. Casarett. 1968. Clinical Radiation Pathology. W. B. Saunders, Philadelphia. 423-470.
248. Yamada, M., S. Kudoh, K. Hirata, T. Nakajima, and J. Yoshikawa. 1998. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur. J. Cancer 34:71-75.
249. Fryer, C. J. H., P. J. Fitzpatrick, W. D. Rider, and P. Poon. 1978. Radiation pneumonitis: experience following a large single dose of radiation. Int. J. Rad. Oncol. Biol. Phys. 4:931-936.
250. Huseby, J. S., and L. D. Hudson. 1976. Miliary tuberculosis and adult respiratory distress syndrome. Ann. Intern. Med. 85:609-611.
251. Piqueras, A. R., L. Marruecos, A. Artigas, and C. Rodriguez. 1987. Miliary tuberculosis and adult respiratory distress syndrome. Intensive Care Med. 13:175-182.
252. Dyer, R. A., W. A. Chappell, and P. D. Potgieter. 1985. Adult respiratory distress syndrome associated with miliary tuberculosis. Crit. Care Med. 13:12-15.
253. Murray, H. W., C. U. Tuazon, N. Kirmani, and J. N. Sheagren. 1978. The adult respiratory distress syndrome associated with mitiary tuberculosis. Chest 73:37-43.
254. Gachot, B., M. Wolff, B. Clair, and B. Regnier. 1990. Severe tuberculosis in patients with human immunodeficiency virus infection. Intensive Care Med. 16:491-493.
255. Hill, A. R., S. Premkumar, S. Brustein, K. Vaidya, S. Powell, P. W. Li, and B. Suster. 1991. Disseminated tuberculosis in the acquired immunodeficiency syndrome era. Am. Rev. Respir. Dis. 144:1164-1170.
256. Tongnian, S., Y. Jiayu, Z. Liye, D. Weiwu, and S. Zhaoying. 1981. Chemotherapy and its combination with corticosteroids in acute miliary tuberculosis in adolescents and adults: analysis of 55 cases. Chin. Med. J. 94:309-314.
257. Blum, R. H., S. K. Carter, and K. Agre. 1973. A clinical review of bleomycin-a new antineoplastic agent. Cancer 31:903-914.
258. Yagoda, A., B. Mukherji, C. Young, E. Etcubanas, C. Lamonte, J. R. Smith, C. T. C. Tan, and I. H. Krakoff. 1972. Bleomycin, an anti-tumor antibiotic: clinical experience in 274 patients. Ann. Intern. Med. 77:861-870.
259. Samuels, M. L., D. E. Johnson, P. Y. Holoye, and V. J. Lanzotti. 1976. Large-dose bleomycin therapy and pulmonary toxicity. J.A.M.A. 235:1117-1120.
260. White, D. A., and D. E. Stover. 1984. Severe bleomycin-induced pneumonitis: clinical features and response to corticosteroids. Chest 86:723-728.
261. McLeod, B. F., J. Lawrence, D. W. Smith, P. J. Vogt, and D. R. Gandara. 1987. Fatal bleomycin toxicity from a low cumulative dose in a patient with renal insufficiency. Cancer 60:2617-2620.
262. McCusker, K., R. A. Dorman, D. P. Nicholson, and A. J. Hough. 1983. Reversible pulmonary injury after a small dose of bleomycin. South. Med. J. 76:1447-1449.
263. Bauer, K. A., A. T. Skarin, J. P. Balikian, M. B. Garnick, D. S. Rosenthal, and G. P. Canellos. 1983. Pulmonary complications associated with combination chemotherapy programs containing bleomycin. Am. J. Med. 74:557-563.
264. Iacovino, J. R., J. Leitner, A. K. Abbas, J. L. Lokich, and G. L. Snider. 1976. Fatal pulmonary reaction from low doses of bleomycin: an id-iosyneratic tissue response. J.A.M.A. 235:1253-1255.
265. Einhorn, L., M. Krause, N. Hornback, and B. Furnas. 1976. Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer. Cancer 37:2414-2416.
266. Nygaard, K., N. Smith-Erichsen, R. Hatlevoll, and S. B. Refsum. 1978. Pulmonary complications after bleomycin. irradiation, and surgery for esophageal cancer. Cancer 41:17-22.
267. Catane, R., J. G. Schwade, A. T. Turrisi III, B. L. Webber, und F. M. Muggia. 1979. Pulmonary toxicity after radiation and bleomycin: a review. Int. J. Radiat. Oncol. Biol. Phys. 5:1513-1518.
268. Bennett, W. M., L. Pastore, and D. C. Houghton. 1980. Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure. Cancer Treat. Rep. 64:921-924.
269. Goldiner, P. L., G. C. Carlon, E. Cvítkovíc, O. Schweizer, and W. S. Howland. 1978. Factors influencing postoperative morbidity and modality in patients treated with bleomycin. Br. Med. J. 1:1664-1667.
270. Gilson. A. J., and S. A. Sahn. 1985. Reactivation of bleomycin lung toxicity following oxygen administration: a second response to corticosteroids. Chest 88:304-306.
271. Holoye, P. Y., M. A. Luna, B. MacKay, and C. W. M. Bedrossian. 1978. Bleomycin hypersensitivity pneumonitis. Ann. Intern. Med. 88:47-49.
272. Yousem, S. A., J. D. Lifson, and T. V. Colby. 1985. Chemotherapy-induced eosinophilic pneumonia: relation to bleomycin. Chest 88:103-106.
273. O'Neill, T. J., C. G. Kardinal, and L. M. Tierney. 1975. Reversible interstitial pneumonitis associated with low dose bleomycin. Chest 68:265-267.
274. Brown, W. G., F. M. Hasan, and R. A. Barbee. 1978. Reversibility of severe bleomycin-induced pneumonitis. J.A.M.A. 239:2012-2014.
275. Ingrassia, T. S., III, J. H. Ryu, V. F. Trastek, and E. C. Rosenow III. 1991. Oxygen-exacerbated bleomycin pulmonary toxicity. Mayo Clin. Proc. 66:173-178.
276. Rudders, R. A., and G. T. Hensley. 1973. Bleomycin pulmonary toxicity. Chest 63:626-628.
277. Orwoll, E. S., P. J. Kiessling, and J. R. Patterson. 1978. Interstitial pneumonia from mitomycin. Ann. Intern. Med. 89:352-355.
278. Buzdar, A. U., S. S. Legha, M. A. Luna, C. K. Tashima, G. N. Hortobagyi, and G. R. Blumenschein. 1980. Pulmonary toxicity of mitomycin. Cancer 45:236-244.
279. Chang, A. Y. C., P. Kuebler, K. J. Pandya, R. H. Israel, B. C. Marshall, and D. C. Tormey, 1986. Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids. Cancer 57:2285-2290.
280. Gunstream, S. R., J. J. Scidenfeld, R. F. Sobonya, and L. J. McMahon. 1983. Mitomycin-associated lung disease. Cancer Treat. Rep. 67:301-304.
281. Cantrell, J. E., T. M. Philips, and P. S. Schein. 1985. Carcinoma-associated hemolytic uremic syndrome: a complication of mitomycin C chemotherapy. J. Clin. Oncol 3:723-734.
282. Jolivet, J., L. Giroux, S. Laurin, J. Gruber, P. Bettez, and P. R. Band. 1983. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome. Cancer Treat. Rep. 67:429-434.
283. Sheldon, R., and D. Slaughter. 1986. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma. Cancer 58:1428-1436.
284. Verweij, J., M. E. L. van der Burg, and H. M. Pinedo. 1987, Mitomycin C-induced hemolytic uremic syndrome: six case reports and review of the literature on renal, pulmonary, and cardiac side effects of the drug. Radiother. Oncol. 8:33-41.
285. Luedke, D., T. T. McLaughlin, C. Daughaday, S. Luedke, B. Harrison, G. Reed, and O. Martello, 1985. Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression, Cancer 55:542-545.
286. Kris, M. G., D. Pablo, R. J. Gralla, M. T. Burke, J. Prestifilippo, and D. Lewin. 1984. Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy. Cancer Treat. Rep. 68:1029-1031.
287. Hoelzer, K. L., B. R. Harrison, S. W. Luedke, and D. W. Luedke. 1986. Vinblastine-associated pulmonary toxicity in patients receiving combination therapy with mitomycin and cisplatin. Drug Intell. Clin. Pharm. 20:287-289.
288. Konits, P. H., J. Aisner, J. C. Sutherland, and P. H. Wiernik. 1982. Possible pulmonary toxicity secondary to vinblastine. Cancer 50:2771-2774.
289. Rao, S. X., G. Ramaswamy, M. Levin, and J. W. McCravey. 1985. Fatal acute respiratory failure after vinblastine-mitomycin therapy in lung carcinoma. Arch. Intern. Med. 145:1905-1907.
290. Kennedy, J. I. 1990. Clinical aspects of amiodarone pulmonary toxicity. Clin. Chest Med. 11:119-129.
291. Martin, W. J., II, and E. C. Rosenow III. 1988. Amiodarone pulmonary toxicity: recognition and pathogenesis (Part 1). Chest 93:1067-1075.
292. Morady, F., M. J. Sauve, P. Malone, E. N. Shen, A. B. Schwartz, A. Bhandari, E. Keung, R. J. Sung, and M. M. Scheinman. 1983. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular librillation. Am. J. Cardiol, 52:975-979.
293. Dean, P. J., K. D. Groshart, J. G. Porterfield, D. H. Iansmith, and E. B. Golden Jr. 1987. Amiodarone-associated pulmonary toxicity: a clinical and pathologic study of eleven cases. Am. J. Clin. Pathol. 87:7-13.
294. Jirik, F. R., M. Henning. V. F. Huckell, and D. V. N. Ostrow. 1983. Diffuse alveolar damage syndrome associated with amiodarone therapy. Can. Med. Assoc. J. 128:1192-1195.
295. Koslin, D. B., P. Chapman, J. E. Youker, and P. Troup. 1984. Amiodarone-induced pulmonary toxicity. J. Can. Assoc. Radiol. 35:195-198.
296. Sobol, S. M., and L. Rakita. 1982. Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug. Circulation 65:819-824.
297. Kennedy, J. I., J. L. Myers, V. J. Plumb, and J. D. Fulmer. 1987. Amiodarone pulmonary toxicity: clinical, radiologic, and pathologic correlations. Arch. Intern. Med. 147:50-55.
298. Wood, D. L., M. J. Osborn, J. Rooke, and D. R. Holmes, Jr. 1985. Amiodarone pulmonary toxicity: report of two cases associated with rapidly progressive fatal adult respiratory distress syndrome after pulmonary angiography. Mayo Clin. Proc. 60:601-603.
299. Van Mieghem, W., L. Coolen, I. Malysse, L. M. Lacquet, G. J. D. Deneffe, and M. G. P. Demedts. 1994 Amiodarone and the development of ARDS after lung surgery. Chest 105:1642-1645.
300. Greenspon, A. J., G. A, Kidwell, W. Hurley, and J. Mannion. 1991. Amiodarone-related postoperative adult respiratory distress syndrome. Circulation 84(Suppl. 3):407-415.
301. Kay, G. N., A. E. Epstein, J. K. Kirklin, A. G. Diethelm, G. Graybar, and V. J. Plumb. 1988. Fatal postoperative amiodarone pulmonary toxicity. Am. J. Cardiol. 62:490-492.
302. Forrester, J. M., A. W. Steele, J. A. Waldron, and P. E. Parsons. 1990. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am. Rev. Respir. Dis. 142:462-467.
303. Clinicopathologic conference. 1993. Respiratory failure and cosinophilia in a young man. Am. J. Med. 94:533-542.
304. Kissner, D. G., W. D. Lawrence, J. E. Selis, and A. Flint. 1987. Crack lung: pulmonary disease caused by cocaine abuse. Am. Rev. Respir. Dis. 136:1250-1252.
305. Oh, P. I., and M. S. Balter. 1992. Cocaine induced eosinophilic lung disease. Thorax 47:478-479.
306. Orriols, R., X. Munoz, J. Ferrer, P. Huget, and F. Morell. 1996. Cocaine-induced Churg-Strauss vasculitis. Eur. Respir. J. 9:175-177.
307. Patel, R. C., D. Dutta, and S. A. Schonfeld. 1987. Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia. Ann. Intern. Med. 107:186-187.
308. Haim, D. Y., M. L. Lippmann, S. K. Goldberg, and M. D. Walkenstein. 1995. The pulmonary complications of crack cocaine: a comprehensive review. Chest 107:233-240.
309. Fischer, J. R., and R. K. Baer. 1996. Acute myopathy associated with combined use of corticosteroids and neuromuscular blocking agents. Ann. Pharmacother. 30:1437-1445.
310. Watling, S. M., and J. F. Dasta. 1994. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature. Crit. Care Med. 22:884-893.
311. Griffin, D., N. Fairman, D. Coursin, L. Rawsthorne, and J. E. Grossman. 1992. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 102:510-514.
312. Lacomis, D., M. J. Giuliani, A. Van Cott, and D. J. Kramer. 1996. Acute myopathy of intensive care: clinical, electromyographic, and pathologic aspects. Ann. Neural. 40:645-654.
313. Douglass, J. A., D. V. Tuxen, M. Horne, C. D. Scheinkelstel, M. Weinmann, D. Czarny, and G. Bowes. 1992. Myopathy in severe asthma. Am. Rev. Respir. Dis. 146:517-519.
314. Leatherman, J. W., W. L. Fluegel, W. S. David, S. F. Davies, and C. Iber. 1996. Muscle weakness in mechanically ventilated patients with severe asthma. Am. J. Respir. Crit. Care Med. 153:1686-1690.
315. Williams, T. J., R. E. O'Hehir, D. Czarny, M. Horne, and G. Bowes. 1988. Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids. Am. Rev. Respir. Dis. 137:460-463.
316. Hanson, P., A. Dive, J. M. Brucher, M. Bisteau, M. Dangoisse, and T. Deltombe. 1997. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 20:1371-1380.
317. Faragher, M. W., B. J. Day, and X. Dennett. 1996. Critical care myopathy: an electrophysiological and histological study. Muscle Nerve 19:516-518.
318. Hirano, M., B. R. Ott, E. C. Raps, C. Minetti, L. Lennihan, N. P. Libbey, E. Bonilla, and A. P. Hays. 1992. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 42:2082-2087.
319. Dekhuijzen, P. N. R., and M. Decramer. 1992. Steroid-induced myopathy und its significance to respiratory disease: a known disease rediscovered. Eur. Respir. J. 5:997-1003.
320. Gallagher, C. G. 1994. Respiratory steroid myopathy [Editorial]. Am. J. Respir. Crit. Care Med. 150:4-6.
321. Murrieta-Aguttes, M., V. Michelen, F. Leynadier, C. Duarte-Risselin, G. M. Halpern, and J. Dry. 1991. Systemic allergic reactions to corticosteroids. J. Asthma 28:329-339.
322. McNamara, R. M. 1986. Anaphylaxis after intravenous corticosteroid administration. J. Emerg. Med. 4:213-215.
323. Vincent, F. M. 1995. The neuropsychiatric complications of corticosteroid therapy. Compr. Therapy 21:524-528.
324. Peet, M., and S. Peters. 1995. Drug-induced mania. Drug Safety 12:146-153.
325. McEvoy, C. E., and D. E. Niewoehner. 1997. Adverse effects of corticosteroid therapy for COPD: a critical review. Chest 111:732-743.
326. Keenan, G. F. 1997. Management of complications of glucocorticoid therapy. Clin. Chest Med. 18:507-520.